Whalegun
Lobbying

Grand River Aseptic Manufacturing's latest lobbying report covers Q3 2023, at $50K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Grand River Aseptic Manufacturing

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Grand River Aseptic Manufacturing lobbying by quarter
Grand River Aseptic Manufacturing lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$200K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)4 reports
  • HOUSE OF REPRESENTATIVES4 reports
  • SENATE4 reports

Firms it paid

Firm
Todd Strategy Group$200K4 quarters

Former officials lobbying for it

Former position
DANIEL M TODDSenior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & MedicaidQ3 2023
PAUL EDATTELChief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John ShadeggQ3 2023
TAYLOR SEXTONAdvisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael BurgessQ3 2023

Lobbying reports

Filed by
24/01/22for Q3 2023Todd Strategy Group$50K
23/10/20for Q3 2023Todd Strategy Group$50K
23/07/20for Q2 2023Todd Strategy Group$50K
23/04/20for Q1 2023Todd Strategy Group$50K
23/01/20for Q4 2022Todd Strategy Group$50K